Credit Suisse’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
2015
Q1
$3.14M Buy
2014
Q4
$2.39M Buy
2014
Q3
$940K Sell
2014
Q2
$1.93M Sell
2014
Q1
$2.02M Buy
2013
Q4
$1.08M Buy
2013
Q3
$495K Sell
2013
Q2
$1.24M Buy